eResearchTechnology, Inc. to Present at the UBS Global Healthcare Services Conference on February 10, 2009
January 29 2009 - 1:26PM
PR Newswire (US)
PHILADELPHIA, Jan. 29 /PRNewswire-FirstCall/ --
eResearchTechnology, Inc. (ERT), (NASDAQ:ERES), a leading provider
of centralized ECG and eClinical technology, ePRO, and other
services to the pharmaceutical, biotechnology, medical device, and
related industries, announced today that Dr. Michael J. McKelvey,
the Company's President and Chief Executive Officer, is scheduled
to present at the annual UBS Global Healthcare Services Conference
at 2:00 p.m. EST on February 10, 2009 at the Waldorf-Astoria in New
York City, New York. Interested parties may access the presentation
by visiting the Company's corporate website at http://www.ert.com/.
The webcast may also be accessed at
http://cc.talkpoint.com/ubsx001/020909a_cy/?entity=40_0DTK1BE. The
webcast will be available via replay for 90 days. Based in
Philadelphia, PA, eResearchTechnology, Inc. (http://www.ert.com/)
is a provider of technology and services to the pharmaceutical,
biotechnology and medical device industries on a global basis. The
company is a market leader in providing centralized core-diagnostic
electrocardiographic (ECG) technology and services to evaluate
cardiac safety in clinical development. The company is also a
leader in providing technology and services to streamline the
clinical trials process by enabling its customers to automate the
collection, analysis, and distribution of clinical data in all
phases of clinical development. Statements included in this release
may constitute forward-looking statements within the meaning of the
Private Securities Litigation Reform Act of 1995. Such statements,
including but not limited to 2008 financial guidance, involve a
number of risks and uncertainties such as the company's ability to
obtain new contracts and accurately estimate net revenues due to
uncertain regulatory guidance, variability in size, scope and
duration of projects, and internal issues at the sponsoring client,
integration of acquisitions, competitive factors, technological
development, and market demand. As a result, actual results may
differ materially from any financial outlooks stated herein.
Further information on potential factors that could affect the
company's financial results can be found in the company's Reports
on Form 10-K and 10-Q filed with the Securities and Exchange
Commission. The company undertakes no obligation to publicly update
any forward-looking statement, whether as a result of new
information, future events, or otherwise. DATASOURCE:
eResearchTechnology, Inc. CONTACT: Keith Schneck, CFO of
eResearchTechnology, Inc., +1-215-972-0420, Web Site:
http://www.ert.com/
Copyright
East Resources Acquisition (NASDAQ:ERES)
Historical Stock Chart
From Jun 2024 to Jul 2024
East Resources Acquisition (NASDAQ:ERES)
Historical Stock Chart
From Jul 2023 to Jul 2024
Real-Time news about East Resources Acquisition Company (NASDAQ): 0 recent articles
More Eresearch Technology Inc. (MM) News Articles